APA (7th ed.) Citation

ME, M., M, d. L., JA, B., T, C., WR, L., J, R., . . . DM, C. (2026). Donidalorsen for hereditary angioedema: Long-term results from a 4-year, phase 2, open-label extension study. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 136(6), 699. https://doi.org/10.1016/j.anai.2026.02.019

Chicago Style (17th ed.) Citation

ME, Manning, et al. "Donidalorsen for Hereditary Angioedema: Long-term Results from a 4-year, Phase 2, Open-label Extension Study." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology 136, no. 6 (2026): 699. https://doi.org/10.1016/j.anai.2026.02.019.

MLA (9th ed.) Citation

ME, Manning, et al. "Donidalorsen for Hereditary Angioedema: Long-term Results from a 4-year, Phase 2, Open-label Extension Study." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, vol. 136, no. 6, 2026, p. 699, https://doi.org/10.1016/j.anai.2026.02.019.